Search Results

Filter
  • 1-10 of  345 results for ""COMPANION diagnostics""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Nuclear Theranostics in Asia: In vivo Companion Diagnostics.

  • Authors : Lee DS; Seoul National University, Seoul, South Korea.; Cheon GJ

  • Source: Nuclear medicine and molecular imaging [Nucl Med Mol Imaging] 2019 Feb; Vol. 53 (1), pp. 1-6. Date of Electronic Publication: 2019 Jan 15.Publisher: Springer Country of Publication: Germany NLM ID: 101530478 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review.

  • Authors : Matsubayashi H; Division of Genetic Medicine Promotion, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi, Suntogun, Shizuoka, 411-8777, Japan. .; Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan. .

Subjects: Piperazines*/Piperazines*/Piperazines*/therapeutic use ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/drug therapy ; Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/genetics Folfox protocol

  • Source: Familial cancer [Fam Cancer] 2024 Aug; Vol. 23 (3), pp. 393-398. Date of Electronic Publication: 2024 May 11.Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Familial and hereditary pancreatic cancer in Japan.

  • Authors : Matsubayashi H; Division of Genetic Medicine Promotion and Endoscopy, Shizuoka Cancer Center, Shimonagakubo, Nagaizumi, Suntogun, Shizuoka, 411-8777, Japan. .; Morizane C

Subjects: Pancreatic Neoplasms*/Pancreatic Neoplasms*/Pancreatic Neoplasms*/genetics ; Genetic Predisposition to Disease*; Humans Pancreatic carcinoma, familial

  • Source: Familial cancer [Fam Cancer] 2024 Aug; Vol. 23 (3), pp. 365-372. Date of Electronic Publication: 2024 May 11.Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Comprehensive genomic profiling for oncological advancements by precision medicine.

  • Authors : Pankiw M; Department of Medicine, Mount Sinai Hospital, Toronto, ON, Canada.; Department of Pathology and Lab Medicine, Mount Sinai Hospital, Toronto, ON, Canada.

Subjects: Precision Medicine*/Precision Medicine*/Precision Medicine*/methods ; Medical Oncology*; Humans

  • Source: Medical oncology (Northwood, London, England) [Med Oncol] 2023 Nov 22; Vol. 41 (1), pp. 1. Date of Electronic Publication: 2023 Nov 22.Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Predictors of thyroid adverse events during cancer immunotherapy: a real-life experience at a single center.

  • Authors : Ruggeri RM; Endocrinology Unit, Department of Human Pathology of Adulthood and Childhood DETEV 'G. Barresi', University of Messina, Messina, Italy. .; Medical Oncology Unit, Department of Human Pathology of Adulthood and Childhood DETEV 'G. Barresi', University of Messina, Messina, Italy. .

Subjects: Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/Carcinoma, Non-Small-Cell Lung*/drug therapy ; Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/Antineoplastic Agents, Immunological*/adverse effects ; Lung Neoplasms*/Lung Neoplasms*/Lung Neoplasms*/drug therapy

  • Source: Journal of endocrinological investigation [J Endocrinol Invest] 2023 Nov; Vol. 46 (11), pp. 2399-2409. Date of Electronic Publication: 2023 Apr 20.Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Recent advances in the molecular targeted drugs for prostate cancer.

  • Authors : Gao P; Department of Urology, Guizhou Provincial People's Hospital, Guiyang, 550002, China.; Li T

Subjects: Molecular Targeted Therapy*/Molecular Targeted Therapy*/Molecular Targeted Therapy*/adverse effects ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy; Humans

  • Source: International urology and nephrology [Int Urol Nephrol] 2023 Apr; Vol. 55 (4), pp. 777-789. Date of Electronic Publication: 2023 Jan 31.Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  345 results for ""COMPANION diagnostics""